Literature DB >> 27737841

Diagnostic Test Accuracy in Childhood Pulmonary Tuberculosis: A Bayesian Latent Class Analysis.

Samuel G Schumacher, Maarten van Smeden, Nandini Dendukuri, Lawrence Joseph, Mark P Nicol, Madhukar Pai, Heather J Zar.   

Abstract

Evaluation of tests for the diagnosis of childhood pulmonary tuberculosis (CPTB) is complicated by the absence of an accurate reference test. We present a Bayesian latent class analysis in which we evaluated the accuracy of 5 diagnostic tests for CPTB. We used data from a study of 749 hospitalized South African children suspected to have CPTB from 2009 to 2014. The following tests were used: mycobacterial culture, smear microscopy, Xpert MTB/RIF (Cepheid Inc.), tuberculin skin test (TST), and chest radiography. We estimated the prevalence of CPTB to be 27% (95% credible interval (CrI): 21, 35). The sensitivities of culture, Xpert, and smear microscopy were estimated to be 60% (95% CrI: 46, 76), 49% (95% CrI: 38, 62), and 22% (95% CrI: 16, 30), respectively; specificities of these tests were estimated in accordance with prior information and were close to 100%. Chest radiography was estimated to have a sensitivity of 64% (95% CrI: 55, 73) and a specificity of 78% (95% CrI: 73, 83). Sensitivity of the TST was estimated to be 75% (95% CrI: 61, 84), and it decreased substantially among children who were malnourished and infected with human immunodeficiency virus (56%). The specificity of the TST was 69% (95% CrI: 63%, 76%). Furthermore, it was estimated that 46% (95% CrI: 42, 49) of CPTB-negative cases and 93% (95% CrI: 82; 98) of CPTB-positive cases received antituberculosis treatment, which indicates substantial overtreatment and limited undertreatment.
© The Author 2016. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  specificity; childhood pulmonary tuberculosis; diagnosis; latent class analysis; overtreatment; sensitivity

Mesh:

Year:  2016        PMID: 27737841      PMCID: PMC5100832          DOI: 10.1093/aje/kww094

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

Review 1.  Evaluation of diagnostic tests when there is no gold standard. A review of methods.

Authors:  A W S Rutjes; J B Reitsma; A Coomarasamy; K S Khan; P M M Bossuyt
Journal:  Health Technol Assess       Date:  2007-12       Impact factor: 4.014

Review 2.  Tuberculosis in children.

Authors:  Carlos M Perez-Velez; Ben J Marais
Journal:  N Engl J Med       Date:  2012-07-26       Impact factor: 91.245

3.  Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.

Authors:  Heather J Zar; Lesley Workman; Washiefa Isaacs; Keertan Dheda; Widaad Zemanay; Mark P Nicol
Journal:  Lancet Glob Health       Date:  2013-07-24       Impact factor: 26.763

Review 4.  Pediatric tuberculosis: global overview and challenges.

Authors:  Soumya Swaminathan; Banu Rekha
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 5.  Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.

Authors:  Helen E Jenkins; Arielle W Tolman; Courtney M Yuen; Jonathan B Parr; Salmaan Keshavjee; Carlos M Pérez-Vélez; Marcello Pagano; Mercedes C Becerra; Ted Cohen
Journal:  Lancet       Date:  2014-03-24       Impact factor: 79.321

Review 6.  Diagnosis of pulmonary tuberculosis in children: new advances.

Authors:  Heather J Zar; Tom G Connell; Mark Nicol
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

7.  Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens.

Authors:  Heather J Zar; Lesley Workman; Washiefa Isaacs; Jacinta Munro; Faye Black; Brian Eley; Veronica Allen; Catharina C Boehme; Widaad Zemanay; Mark P Nicol
Journal:  Clin Infect Dis       Date:  2012-07-02       Impact factor: 9.079

8.  Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital.

Authors:  Lisine Tuyisenge; C Patrick Ndimubanzi; Gilles Ndayisaba; Narcisse Muganga; Joris Menten; Marleen Boelaert; Jef Van den Ende
Journal:  Pediatr Infect Dis J       Date:  2010-02       Impact factor: 2.129

9.  Cutaneous testing in the elderly patient with tuberculosis.

Authors:  J H Battershill
Journal:  Chest       Date:  1980-02       Impact factor: 9.410

Review 10.  Estimation of diagnostic test accuracy without full verification: a review of latent class methods.

Authors:  John Collins; Minh Huynh
Journal:  Stat Med       Date:  2014-06-09       Impact factor: 2.373

View more
  23 in total

1.  Serologic Responses in Childhood Pulmonary Tuberculosis.

Authors:  Bareng A S Nonyane; Mark P Nicol; Nicholas J Andreas; Stefanie Rimmele; Nicole Schneiderhan-Marra; Lesley J Workman; Mark D Perkins; Thomas Joos; Tobias Broger; Jerrold J Ellner; David Alland; Beate Kampmann; Susan E Dorman; Heather J Zar
Journal:  Pediatr Infect Dis J       Date:  2018-01       Impact factor: 2.129

2.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

3.  Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.

Authors:  Ruvandhi R Nathavitharana; Christina Yoon; Peter Macpherson; David W Dowdy; Adithya Cattamanchi; Akos Somoskovi; Tobias Broger; Tom H M Ottenhoff; Nimalan Arinaminpathy; Knut Lonnroth; Klaus Reither; Frank Cobelens; Christopher Gilpin; Claudia M Denkinger; Samuel G Schumacher
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

Review 4.  Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.

Authors:  Alexander W Kay; Tara Ness; Sabine E Verkuijl; Kerri Viney; Annemieke Brands; Tiziana Masini; Lucia González Fernández; Michael Eisenhut; Anne K Detjen; Anna M Mandalakas; Karen R Steingart; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2022-09-06

5.  Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests.

Authors:  Emily L MacLean; Mikashmi Kohli; Lisa Köppel; Ian Schiller; Surendra K Sharma; Madhukar Pai; Claudia M Denkinger; Nandini Dendukuri
Journal:  Diagn Progn Res       Date:  2022-06-16

Review 6.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

7.  Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.

Authors:  Heather J Zar; Lesley J Workman; Margaretha Prins; Linda J Bateman; Slindile P Mbhele; Cynthia B Whitman; Claudia M Denkinger; Mark P Nicol
Journal:  Am J Respir Crit Care Med       Date:  2019-12-15       Impact factor: 21.405

8.  On the robustness of latent class models for diagnostic testing with no gold standard.

Authors:  Matthew R Schofield; Michael J Maze; John A Crump; Matthew P Rubach; Renee Galloway; Katrina J Sharples
Journal:  Stat Med       Date:  2021-05-14       Impact factor: 2.497

9.  Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.

Authors:  Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27

10.  Validity of ICD-based algorithms to estimate the prevalence of injection drug use among infective endocarditis hospitalizations in the absence of a reference standard.

Authors:  Kaitlin M McGrew; Hélène Carabin; Tabitha Garwe; S Reza Jafarzadeh; Mary B Williams; Yan Daniel Zhao; Douglas A Drevets
Journal:  Drug Alcohol Depend       Date:  2020-03-04       Impact factor: 4.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.